Best Intramuscular Antipsychotic for Acute Agitation
For rapid control of agitation in adults, use IM haloperidol 5 mg or IM ziprasidone 20 mg as first-line monotherapy, with ziprasidone preferred when available due to significantly lower extrapyramidal side effects while maintaining comparable efficacy. 1
Primary Recommendations by Clinical Context
Undifferentiated Agitation (Unknown Etiology)
- First-line options: Haloperidol 5 mg IM OR ziprasidone 20 mg IM 1
- For fastest sedation: Consider droperidol 5 mg IM if available and no cardiac contraindications exist 1
- Droperidol produces significantly better sedation than haloperidol from 5-60 minutes
- Requires fewer repeat doses and shorter ED length of stay
- Despite FDA black box warning, large safety series (>12,000 patients) show minimal cardiac events 1
Known Psychiatric Illness (Schizophrenia, Psychosis)
Geriatric Patients (Age >65)
- Avoid midazolam entirely - elevated risk of serious adverse events without efficacy gains 3
- Preferred: Oral quetiapine if patient cooperative (best safety profile) 3
- If IM required: Use lowest effective doses; serious adverse events occurred in 16.8% of older adults receiving antipsychotics/anxiolytics 3
- Olanzapine IM recommended over haloperidol due to lower adverse effect profile 4
Dosing Strategy
Haloperidol
- Standard dose: 5 mg IM 1
- Extensive evidence base (20+ double-blind studies since 1973)
- Higher extrapyramidal symptom risk than atypicals
Ziprasidone
- Optimal dose: 20 mg IM (NOT 10 mg) 1
- Can repeat every 4-6 hours as needed
- 10 mg dose significantly less effective than 20 mg
- Decreased restraint time compared to haloperidol/lorazepam combination 1
Droperidol
- Dose: 5 mg IM/IV 1
- Fastest onset of action
- Safety data from 2,468 ED patients shows minimal adverse events (6 total, none dysrhythmic) 1
Combination Therapy
Haloperidol 5 mg IM + lorazepam 2 mg IM may produce more rapid sedation than monotherapy in psychiatric patients, though this is a Level C recommendation 1
Critical Safety Considerations
QTc Prolongation
- All antipsychotics prolong QTc at maximum doses, but none exceeded 500 ms in studies 1
- Thioridazine has greatest QTc change; olanzapine has least
- Droperidol concerns largely unsubstantiated by clinical data 1
Extrapyramidal Symptoms
- Highest risk: Haloperidol (36.9% in Chinese study) 2
- Lowest risk: Ziprasidone (2.1%), aripiprazole 2, 5
- Consider prophylactic diphenhydramine with haloperidol if EPS history
Route-Specific Risks
- IV/IM administration increases adverse event risk versus oral 3
- Favor oral formulations when patient cooperative
- Use lowest effective dose, especially in elderly 3
Common Pitfalls to Avoid
Don't use anticholinergic antipsychotics (thioridazine) in suspected anticholinergic toxicity or sympathomimetic ingestion 1
Don't underdose ziprasidone - 10 mg significantly less effective than 20 mg 1
Don't reflexively avoid droperidol due to FDA warning - safety data from >12,000 patients contradicts black box concerns 1
Don't use midazolam in geriatric patients - unacceptable risk-benefit ratio 3
Identify reversible medical causes before sedating - agitation may indicate delirium, hypoxia, or metabolic derangement 1
Efficacy Comparison
Rescue medication rates at 1 hour (lower is better):
Time to significant effect:
- Aripiprazole 9.75 mg: 30-45 minutes 5
- Ziprasidone 20 mg: Rapid onset, sustained through 4-6 hours 1
- Haloperidol: 105 minutes 5
Algorithm for Selection
- Patient cooperative? → Oral risperidone + lorazepam 1
- Age >65? → Avoid midazolam; prefer oral quetiapine or low-dose olanzapine IM 3, 4
- Need fastest sedation? → Droperidol 5 mg (if no cardiac contraindications) 1
- Known psychosis? → Ziprasidone 20 mg IM (best tolerability) 1, 2
- Undifferentiated agitation? → Haloperidol 5 mg IM OR ziprasidone 20 mg IM 1
- Inadequate response at 1 hour? → Repeat same agent or add lorazepam 2 mg 1